Model Informed Drug Development and Regulation in China: Challenges and Opportunities

CPT Pharmacometrics Syst Pharmacol. 2019 Feb;8(2):59-61. doi: 10.1002/psp4.12368. Epub 2019 Jan 4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • China
  • Drug Development / legislation & jurisprudence
  • Drug Development / methods*
  • Drugs, Generic
  • Guidelines as Topic
  • Humans
  • Legislation, Drug / organization & administration*
  • Models, Theoretical

Substances

  • Drugs, Generic